Clinical Trials
2 trialsNCT00957853 2020-03-19
Preoperative Treatment With Cetuximab and/or IMC-A12
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00617734 2018-04-17
Study of IMC-A12, Alone or in Combination With Cetuximab, in Participants With Recurrent or Metastatic Squamous Cell Carcinoma (MSCC) of the Head and Neck
Eli Lilly and Company
Phase 2 Completed